TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.

Jean-Luc Van Laethem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.